News for Sight Sciences, Inc. (SGHT)

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. ( SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on

**media[602242]**

Australia-based Innovation Beverage Group Limited (IBG) is up over 192 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ETCompany ParticipantsPhilip Trip Taylor - IRPaul Badawi -...

While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sight Sciences (SGHT) delivered earnings and revenue surprises of -15% and 0.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[558433]**

Sight Sciences Inc (SGHT) is set to release its Q4 2024 earnings on Mar 5, 2025. The consensus estimate for Q4 2024 revenue is $19.92 million, and the earnings

Sight Sciences (SGHT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical Practice, Demonstrates Significant, Long-

**media[544994]**

**media[540312]**

On January 16, 2025, Long Focus Capital Management, LLC (Trades, Portfolio) executed a significant transaction involving Sight Sciences Inc (SGHT). The firm add

Sight sciences CEO Paul Badawi sells shares worth $72,570

Sight sciences chief legal officer sells shares worth $19,250

Sight sciences CTO David Badawi sells $15,081 in stock

Sight sciences chief legal officer Jeremy Hayden sells $5,898 in stock

**media[508694]**

**media[508693]**